Roche Holding AG (RHHBY) News Headlines

▮ More

Date

Headline

8/16/2019 1:20:13 AM Roche Reports FDA Approval Of Rozlytrek - Quick Facts

8/16/2019 1:08:04 AM Roche: FDA Approved Rozlytrek For Adults With ROS1-positive, Metastatic NSCLC

8/5/2019 8:27:18 AM Roche Diagnostics Canada Appoints Andrew Plank As President And General Manager

8/5/2019 1:31:13 AM Roche's Tecentriq Phase III IMvigor130 Study Meets Co-primary Endpoint

8/5/2019 1:12:16 AM Roche Says Phase III IMvigor130 Study Meets Co-primary Endpoint

7/31/2019 1:30:06 AM Roche And Spark Therapeutics Extend Tender Offer For Shares Of Spark Therapeutics To Sept 3

7/29/2019 7:28:28 AM Biotech Stocks Facing FDA Decision In August 2019

7/26/2019 7:17:39 AM Roche: CHMP Recommends EU Approval Of Tecentriq Combination With Chemotherapy

7/25/2019 1:33:44 AM Roche H1 Profit Rises, Sales Up 9%; Raises 2019 Outlook - Quick Facts

7/25/2019 1:03:26 AM Roche H1 Group Sales Up 9% To CHF 30.5 Bln

7/23/2019 2:10:56 AM Sanofi Gains US OTC Rights For Tamiflu To Treat Influenza - Quick Facts

7/22/2019 1:08:24 AM Roche Announces Expansion Of The Global Access Program

7/16/2019 8:37:15 AM Convelo Therapeutics Enters Exclusive Worldwide Collaboration With Genentech

7/9/2019 1:17:33 AM Roche Presents Positive Hemlibra Data Across Multiple Pivotal Studies

7/9/2019 1:03:30 AM Roche Announces New Data For Hemlibra Across Multiple Pivotal Studies

7/8/2019 10:06:28 PM Roche And Spark Therapeutics Agree To Extend Merger Deadline

7/3/2019 1:34:42 AM Genentech: Late-stage Study On Xofluza Shows Well-tolerated In Children With Flu

7/3/2019 1:03:22 AM Genentech Announces Phase III MINISTONE-2 Study Meets Primary Endpoint

6/13/2019 1:26:48 AM Genentech: Phase III PEMPHIX Study With Rituxan Meets Primary End Point

6/13/2019 1:04:16 AM Genentech Announces Positive Top Line Results From Phase III PEMPHIX Study

Roche Holding Ag (RHHBY)